Moomoo AI 已提取核心訊息
Safety Shot, Inc. has filed an amendment to its Quarterly Report for the period ended September 30, 2023, reflecting a reclassification of financial statements due to the separation of SRM Ltd from the company. The separation, which included an exchange of shares and an IPO for SRM, resulted in Safety Shot owning 4,500,000 shares of SRM's outstanding common stock. Consequently, SRM is no longer consolidated and is accounted for using the equity method. Financial performance for the three and nine months ended September 30, 2023, shows a net loss of $7,738,301 and $9,406,066 respectively, with a basic loss per share of $0.26 and $0.34. The company's cash position improved to $4,387,797 from $1,477,552 at the end of the previous year. Safety Shot, Inc. launched the Safety Shot product in...Show More
Safety Shot, Inc. has filed an amendment to its Quarterly Report for the period ended September 30, 2023, reflecting a reclassification of financial statements due to the separation of SRM Ltd from the company. The separation, which included an exchange of shares and an IPO for SRM, resulted in Safety Shot owning 4,500,000 shares of SRM's outstanding common stock. Consequently, SRM is no longer consolidated and is accounted for using the equity method. Financial performance for the three and nine months ended September 30, 2023, shows a net loss of $7,738,301 and $9,406,066 respectively, with a basic loss per share of $0.26 and $0.34. The company's cash position improved to $4,387,797 from $1,477,552 at the end of the previous year. Safety Shot, Inc. launched the Safety Shot product in December 2023, expanding its product pipeline which includes treatments for various health and wellness concerns. The company generates revenue through sales and licensing royalties, with products available through retailers and e-commerce platforms. Despite the net losses, the company has a positive working capital and continues to invest in research and development for its product lines. The report raises concerns about the company's ability to continue as a going concern, with accumulated deficits of $60,003,740 as of September 30, 2023.
Safety Shot, Inc.已提交了截至2023年9月30日的季度報告的修正案，反映了由於SRM Ltd脫離公司而對財務報表進行了重新分類。分離包括股票交換和SRM的首次公開募股，導致Safety Shot擁有SRM已發行普通股的450萬股。因此，SRM不再合併，而是使用權益法進行覈算。截至2023年9月30日的三個月和九個月的財務業績分別顯示淨虧損7,738,301美元和9,406,066美元，基本每股虧損爲0.26美元和0.34美元。該公司的現金狀況從去年年底的1,477,552美元改善至4,387,797美元。Safety Shot, Inc. 於 2023 年 12 月推出了 S...展開全部
Safety Shot, Inc.已提交了截至2023年9月30日的季度報告的修正案，反映了由於SRM Ltd脫離公司而對財務報表進行了重新分類。分離包括股票交換和SRM的首次公開募股，導致Safety Shot擁有SRM已發行普通股的450萬股。因此，SRM不再合併，而是使用權益法進行覈算。截至2023年9月30日的三個月和九個月的財務業績分別顯示淨虧損7,738,301美元和9,406,066美元，基本每股虧損爲0.26美元和0.34美元。該公司的現金狀況從去年年底的1,477,552美元改善至4,387,797美元。Safety Shot, Inc. 於 2023 年 12 月推出了 Safety Shot 產品，擴大了其產品線，其中包括針對各種健康和保健問題的治療。該公司通過銷售和許可使用費創造收入，產品可通過零售商和電子商務平台購買。儘管出現淨虧損，但該公司擁有正的營運資金，並將繼續投資於其產品線的研發。該報告引發了人們對該公司繼續經營能力的擔憂，截至2023年9月30日，累計赤字爲60,003,740美元。
有用
沒用